Durban, South Africa – Today, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR); Janssen Pharmaceutica NV (Janssen), one of the Janssen pharmaceutical companies of Johnson & Johnson; and ViiV Healthcare announced a combined $85 million
Read More...
Read the complete post at https://blog.aids.gov/2016/07/pepfar-and-dreams-partners-announce-winners-of-the-85-million-dreams-innovation-challenge.html
Posted
Jul 18 2016, 07:05 AM
by
blog.aids.gov — HIV Policy & Programs. Research. New Media.